InvestSMART

Lumos Diagnostics Holdings Limited (ASX: LDX) - Announcements

Current share price for LDX : $0.097 0.003 (3%)+

ASX company news and announcements for Lumos Diagnostics Holdings Limited (LDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Lumos Diagnostics Holdings Limited (LDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Lumos Diagnostics Holdings Limited (LDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Lumos Diagnostics Holdings Limited (LDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$92 Application for quotation of securities - LDX 13 Apr 2023 12:53PM $0.023 $0.097 risen by 321.74%
$92 Application for quotation of securities - LDX 5 Apr 2023 11:54AM $0.025 $0.097 risen by 288%
$92 Change in substantial holding 4 Apr 2023 2:35PM $0.025 $0.097 risen by 288%
$92 Change in substantial holding from RYD 30 Mar 2023 4:35PM $0.027 $0.097 risen by 259.26%
$92 Application for quotation of securities - LDX 17 Mar 2023 4:39PM $0.031 $0.097 risen by 212.90%
$92 Lumos to present at NWR Virtual Healthcare Conference 17 Mar 2023 4:33PM $0.031 $0.097 risen by 212.90%
$92 Lumos signs three new agreements with Hologic 16 Mar 2023 9:08AM $0.031 $0.097 risen by 212.90%
$92 Application for quotation of securities - LDX 14 Mar 2023 4:45PM $0.031 $0.097 risen by 212.90%
$92 Change in substantial holding 9 Mar 2023 8:44AM $0.039 $0.097 risen by 148.72%
$92 Investor Presentation 6 Mar 2023 10:22AM $0.042 $0.097 risen by 130.95%
$92 Notification regarding unquoted securities - LDX 2 Mar 2023 4:34PM $0.045 $0.097 risen by 115.56%
$92 Shareholder Webinar 2 Mar 2023 9:36AM $0.043 $0.097 risen by 125.58%
$92 Change in substantial holding 28 Feb 2023 11:45AM $0.050 $0.097 risen by 94%
$92 Lumos Diagnostics FY23 First Half Year Results 27 Feb 2023 8:56AM $0.050 $0.097 risen by 94%
$92 Appendix 4D and Half Year Report 27 Feb 2023 8:48AM $0.050 $0.097 risen by 94%
$92 Change in substantial holding 21 Feb 2023 4:48PM $0.043 $0.097 risen by 125.58%
$92 Change in substantial holding 21 Feb 2023 4:45PM $0.043 $0.097 risen by 125.58%
$92 Change in substantial holding 21 Feb 2023 4:11PM $0.043 $0.097 risen by 125.58%
$92 Becoming a substantial holder 21 Feb 2023 4:11PM $0.043 $0.097 risen by 125.58%
$92 Application for quotation of securities - LDX 20 Feb 2023 4:31PM $0.048 $0.097 risen by 102.08%
$92 Change in substantial holding 10 Feb 2023 12:53PM $0.030 $0.097 risen by 223.33%
$92 Change in substantial holding 3 Feb 2023 12:46PM $0.030 $0.097 risen by 223.33%
$92 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2023 9:14AM $0.032 $0.097 risen by 203.13%
$92 Change in substantial holding 23 Jan 2023 10:28AM $0.036 $0.097 risen by 169.44%
$92 Notification of cessation of securities - LDX 16 Jan 2023 12:17PM $0.047 $0.097 risen by 106.38%

351 - 375 of 551 results

Page 15 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.